Search
Ethyl butyrate
go.drugbank.com/drugs/DB15454ExperimentalEthyl butyrate is under investigation in clinical trial NCT03202342 (fMRI of Hypothalamic Responses to Taste, Temperature and Glucose).
Buprenorphine hemiadipate
go.drugbank.com/drugs/DB16117InvestigationalBuprenorphine hemiadipate is under investigation in clinical trial NCT01582347 (Transfer of Subjects From Subutex/suboxone to RBP-6300).
Foslinanib
go.drugbank.com/drugs/DB16172InvestigationalFoslinanib is under investigation in clinical trial NCT03600233 (Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors).
Radiprodil
go.drugbank.com/drugs/DB12260InvestigationalRadiprodil has been used in trials studying the treatment of Infantile Spasms (IS) and Diabetic Peripheral Neuropathic Pain.
Mesenchymal stem cell-derived exosomes
go.drugbank.com/drugs/DB24445InvestigationalMesenchymal Stem Cell-Derived Exosomes is under investigation in clinical trial NCT07183384 (MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction). … Mesenchymal Stem Cell-Derived Exosomes is a biologic drug.
CRTKVA11-03
go.drugbank.com/drugs/DB33965ExperimentalCRTKVA11-03 is a biologic drug. CRTKVA11-03 is under investigation in clinical trial NCT07826585 (Treatment of Patients With Advanced Solid Tumors Using CRTKVA11-03 TCR-T Cell Injection).
Nizaracianine
go.drugbank.com/drugs/DB21517InvestigationalNizaracianine is a small molecule drug. Nizaracianine is under investigation in clinical trial NCT05752149 (Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial).
SRN-101
go.drugbank.com/drugs/DB33962ExperimentalSRN-101 is under investigation in clinical trial NCT07826949 (A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.). … SRN-101 is a biologic drug.
Tetraarsenic tetrasulfide
go.drugbank.com/drugs/DB19141InvestigationalTetraarsenic tetrasulfide is under investigation in clinical trial NCT05682131 (South China Children Cancer Group - Relapsed-acute Lymphoblastic Leukemia 2022 Protocol).
Substance P
go.drugbank.com/drugs/DB19198InvestigationalSubstance P is under investigation in clinical trial NCT03738878 (Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1).